Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel plus SH003 in solid tumors (Phase I/II)
KCT0004770Phase 2Completed
- Sponsor
- DTNCRO
- Start
- Mar 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, SH003 in bronchial carcinoma, breast cancer, sponsored by DTNCRO. Started Mar 2020; status: completed.
02
Drugs
docetaxelSH003
03
Conditions
bronchial carcinomabreast cancer
Beyond the preview
Go deeper on KCT0004770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004770.